In 2015, the American College of Obstetricians and Gynecologists (ACOG) published Committee Opinion No. 651, formally recognizing the menstrual cycle as a vital sign — diagnostically on par with blood pressure, body temperature, heart rate, and respiratory rate. The framework was reaffirmed in a comprehensive 2024 review and is now embedded in clinical practice guidance from NICHD.
For practitioners working in functional women's health, this framework is foundational. It's also still chronically underused in conventional intake — most clinical encounters assess the traditional four vitals and never ask about the cycle in any meaningful detail. Here's why that's a problem, what the framework actually requires, and how to build it into your intake.
What it means to call the cycle a “vital sign”
The other four vitals share a property: each one reflects, at a glance, whether a major physiologic system is functioning normally. Blood pressure indexes cardiovascular function. Temperature indexes metabolic and immune state. Heart rate and respiratory rate index autonomic balance and oxygenation.
The menstrual cycle indexes:
- The hypothalamic-pituitary-ovarian (HPO) axis
- The hypothalamic-pituitary-adrenal (HPA) axis (cycle and stress are entangled)
- Thyroid function (thyroid dysregulation alters cycle length and bleeding patterns)
- Metabolic health (insulin resistance disrupts ovulation)
- Nutritional status (caloric availability is required for HPO axis function)
- Inflammatory load (heavy bleeding, cycle irregularity often reflect inflammation)
- Mental and emotional health (mood changes track with hormonal phases)
A normal cycle is the body announcing that all of these systems are in balance enough to invest energy in reproductive function. A disrupted cycle is one of the earliest warning signs that something upstream isn't right.
What a “normal” cycle actually looks like
Practitioners need a working definition of normal. The ACOG framework and the 2024 review converge on these markers:
Cycle length
- Normal range: 21-35 days for adults; 21-45 days in the first few years post-menarche
- Cycle-to-cycle variation: within ~9 days is considered regular. Larger variation suggests anovulatory cycles or HPO disruption.
Period (menses) length and flow
- Duration: typically 3-7 days
- Volume: ~30-50 mL total. Practical proxies — fewer than 7 saturated pads/tampons per period, or no flooding through regular protection
- Color: red to dark red at peak flow; brown spotting at the start or end is generally normal
- Clots: small clots can be normal; clots larger than a quarter are not
Ovulation
- Should occur approximately once per cycle, typically 12-16 days before the next period
- Confirmed by: a sustained ~0.4°F basal body temperature rise lasting ~12+ days, or by mid-cycle LH surge on tracking strips, or by mid-luteal progesterone testing
- Cervical fluid pattern: increasingly wet/stretchy around ovulation, then dry/sticky after
Cycle-related symptoms
- Pain: mild cramping is common; pain that interferes with daily function is not normal and warrants investigation
- Mood: mild premenstrual changes are common; severe mood disruption (PMDD criteria) is a clinically distinct pattern requiring attention
- Energy: follicular-phase energy higher than luteal-phase energy is typical; severe crashes are not normal
What cycle deviations tell you
Here's where the “vital sign” framing pays off clinically. Specific deviations point at specific underlying physiology:
| Pattern | Likely systems involved |
|---|---|
| Cycles >35 days, irregular | HPO disruption — PMOS, hypothalamic, thyroid, prolactin |
| Cycles <21 days | Short luteal phase, perimenopause, thyroid, anovulatory |
| Heavy bleeding (menorrhagia) | Estrogen dominance, fibroids, adenomyosis, thyroid, bleeding disorders |
| Painful periods (dysmenorrhea) | Endometriosis, adenomyosis, prostaglandin pattern, pelvic floor |
| Missing periods (amenorrhea) | Hypothalamic amenorrhea, PMOS, pregnancy, POI, thyroid, prolactin |
| Mid-cycle spotting | Low estrogen, ovulation spotting, polyps, hormonal flux |
| Pre-menstrual spotting | Low progesterone, short luteal phase, structural issues |
| Severe PMS/PMDD | Neurosteroid sensitivity, blood sugar instability, thyroid, gut/inflammation |
Notice that each pattern points at multiple possible underlying causes. That's why a complete intake doesn't stop at “is the cycle normal?” — it works through the systems implicated by the specific pattern.
How to make this a real part of intake
1. Build a structured cycle history
At minimum, every new client's intake should capture:
- Age at menarche
- Typical cycle length and variation
- Period duration, flow heaviness, presence/size of clots
- Pain level (0-10) and impact on function
- Mood pattern across the cycle
- Energy pattern across the cycle
- Ovulation signs they've noticed (or whether they've never tracked)
- Hormonal birth control history (past and current)
- Pregnancy and postpartum history
- Any cycle changes in the last 6-12 months
2. Get clients tracking
Self-reported “normal” cycles often turn out to be anything but, once a client actually tracks. The first 60-90 days of work with most clients should include some form of structured cycle tracking — paper chart, app (Read Your Body, Natural Cycles, etc.), or a basal body temperature device.
Three signals to capture at minimum:
- Basal body temperature (waking, before getting out of bed) — confirms ovulation and identifies short luteal phases
- Cervical fluid pattern — characterizes estrogen output across the cycle
- Period start dates and flow — quantifies cycle length and bleeding pattern
3. Re-assess at every session
The cycle changes faster than most other vitals. A client's glucose tolerance may shift over months; her cycle can shift in 28 days. Every check-in should include “what did the last cycle look like?” — and that data should be tracked across sessions so patterns become visible.
4. Communicate to medical providers
When you refer to a physician or work alongside one, the structured cycle data you've collected is genuinely useful to them. A client showing up with a 90-day tracking record showing anovulatory cycles, intermittent mid-cycle bleeding, and a 2-degree BBT swing is a different clinical picture than “my periods are weird.” Be the practitioner who provides that documentation.
Common blind spots
Even experienced practitioners overlook these:
- Clients on hormonal birth control have no cycle vital sign. The bleeding on the pill isn't a period — it's a withdrawal bleed. Your assessment of cycle health for these clients is fundamentally blind. Plan for it: if they ever come off, you'll want a tracking phase.
- “Regular” cycles can still be anovulatory. Some women bleed roughly on schedule without ovulating. Cycle length alone doesn't confirm ovulation. BBT or progesterone testing does.
- Perimenopausal cycle changes are diagnostic. A shortening cycle is one of the earliest perimenopause markers, often appearing 5-10 years before the final period. Recognizing the pattern earlier opens earlier intervention.
- Post-pill cycles take time.Don't treat the first 3-6 months of cycles after discontinuing hormonal birth control as baseline. The HPO axis is recalibrating.
Why this framing matters
Treating the cycle as a vital sign isn't just clinical hygiene. It changes how clients understand their own bodies. A woman who's been told for 20 years that her debilitating periods are just “a rough cycle” experiences a real shift when she hears that bleeding through a tampon every hour is a clinically abnormal vital sign — not a personal misfortune.
The framing transfers agency back to the client. The cycle becomes readable data, not just suffering. That's where the practitioner work begins.